Three investigators from the Division of Pulmonary, Allergy and Critical Care Medicine, part of the Department of Medicine at UAB, have received R35 grants from the National Heart, Lung and Blood Institute, part of the National Institutes of Health.
Steven Rowe, MD, director of the Gregory Fleming James Cystic Fibrosis Research Center, received an Emerging Investigator grant of $6.5 million. Rowe's research program will strive to make decisive advancements in the understanding of airway diseases linked to genetic and acquired CFTR dysfunction (the protein that is responsible for cystic fibrosis).
Edwin Blalock, PhD, Nancy E. Dunlap, MD, Endowed Chair in Pulmonary Disease, received an Outstanding Investigator award of $6.14 million. Blalock's laboratory has identified a novel biomarker for a number of pulmonary diseases, including COPD, cystic fibrosis and ARDS.
Gang Liu, MD, associate professor of medicine, received an Emerging Investigator grant of $5.2 million. Liu's research program will center on the role of pulmonary metabolic dysregulation in the cause and development of lung fibrosis.